U.S. Capital Wealth Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,300	Closed	-$303K	–	672
2024 Q1	$303K	Sell	7,300 -5,275	-42%	-$221K	0.01%	567
2023 Q4	$509K	Sell	12,575 -1,100	-8%	-$42K	0.02%	450
2023 Q3	$535K	Buy	13,675 +1,520	+13%	+$60.5K	0.02%	418
2023 Q2	$494K	Hold	12,155	–	–	0.02%	445
2023 Q1	$509K	Buy	12,155 +160	+1%	+$6.73K	0.02%	426
2022 Q4	$523K	Hold	11,995	–	–	0.02%	443
2022 Q3	$466K	Buy	11,995 +600	+5%	+$25.5K	0.02%	455
2022 Q2	$483K	Sell	11,395 -155	-1%	-$6.73K	0.02%	464
2022 Q1	$526K	Buy	+11,550	New	+$512K	0.02%	504

Other funds holding BME

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.21B AUM 19.13% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

U.S. Capital Wealth Advisors's BME Position: Q2 2024 in Review

U.S. Capital Wealth Advisors sold out of BlackRock Health Sciences Trust (BME) in Q2 2024, closing a stake of 7,300 shares — an estimated $303K sold.

U.S. Capital Wealth Advisors first reported a position in BME in Q1 2022 and held it in 9 quarters. The position peaked at $535K in Q3 2023. 69 funds tracked by Wall St. Rank hold BME as of Q2 2024.

U.S. Capital Wealth Advisors reported no remaining BlackRock Health Sciences Trust position as of Q2 2024 after selling out during the quarter.
U.S. Capital Wealth Advisors sold 7,300 BlackRock Health Sciences Trust shares in Q2 2024, an estimated $303K.
U.S. Capital Wealth Advisors first reported a position in BlackRock Health Sciences Trust in Q1 2022 and held it in 9 quarters.
U.S. Capital Wealth Advisors's BlackRock Health Sciences Trust position peaked at $535K in Q3 2023.
69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2024.

Based on U.S. Capital Wealth Advisors's 13F filing for Q2 2024, filed 11 Jul 2024.